Table 4.

Patient-reported outcomes in flaring vs non-flaring* patients across all followup timepoints.

CharacteristicsMonth 3Month 6Month 9Month 12
Flare, n = 8No Flare, n = 72pFlare, n = 8No Flare, n = 65pFlare, n = 9No Flare, n = 66pFlare, n = 15No Flare, n = 62p
Flare questionnaires
  FLARE-RA total score (0–10)
5.6 (2.8)1.8 (1.6)0.0014.5 (2.5)1.7 (2)0.0025.2 (2.8)1.8 (1.9)0.0014.7 (2.3)1.5 (1.8)< 0.0001
  RA-FQ total score (0–50)
29 (12.3)11.5 (9.3)< 0.000125.3 (13.6)10.5 (9.6)0.00224.4 (14.6)10.8 (9.8)0.00322.6 (11.7)8.6 (7.7)< 0.0001
RA-FQ flare domains
  Pain6.6 (2.8)2.5 (2.1)< 0.00015.9 (2.8)2.3 (2.1)0.0015.6 (2.6)2.2 (2)0.0015.3 (2.6)1.5 (1.5)< 0.0001
  Function5.9 (3.1)2.2 (2.1)0.0025.9 (2.8)1.9 (1.9)< 0.00014.6 (3.2)2.0 (2.2)0.0094.5 (2.6)1.7 (1.6)< 0.0001
  Fatigue6.1 (2.9)2.8 (2.5)0.0024.4 (3.4)2.7 (2.6)0.114.7 (3.2)2.7 (2.4)0.0554.6 (2.9)2.4 (2.3)0.007
  Stiffness5.5 (2.8)2.3 (2)0.0025.3 (3.1)2.1 (2.2)0.0064.8 (3.1)2.2 (2)0.0094.7 (2.6)1.7 (1.7)< 0.0001
Participation5.6 (2.6)1.8 (1.9)0.0013.9 (3.4)1.7 (2.2)0.0314.9 (2.8)1.8 (2.1)0.0013.6 (2.4)1.3 (1.7)0.002
Patient-reported joints
  TJC284.1 (4.5)2.1 (3.3)0.027.3 (7.5)2.4 (4.6)0.0038.6 (6.6)1.7 (3.4)< 0.00015.4 (6.3)1.5 (4)< 0.0001
  SJC283.6 (4.4)1.1 (2.5)0.0015.6 (6.9)0.9 (2.2)0.0035.1 (7.8)0.4 (1.2)< 0.00013.9 (4.5)0.5 (1.4)< 0.0001
  • * Based on the question “Are you experiencing a flare of your RA at this time?” (yes/no). Values are mean (SD) unless otherwise specified. FLARE-RA: Flare Assessment in Rheumatoid Arthritis questionnaire; RA-FQ: OMERACT (Outcome Measures in Rheumatology) Rheumatoid Arthritis Flare Questionnaire; TJC28: tender joint count in 28 joints; SJC28: swollen joint count in 28 joints.